Gaofeng Li

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2019 · 135 citations

Biomarker Analysis, Medicine, Pharmacology +8

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy

Qiuzi Zhong, Liuhua Long, An Liu et al. · Frontiers in Oncology · 2020 · 49 citations · Full text

Biodegradable poly(propylene carbonate)/layered double hydroxide composite films with enhanced gas barrier and mechanical properties

Gaofeng Li, Wenhan Luo, Min Xiao et al. · Chinese Journal of Polymer Science · 2015 · 43 citations

Materials Science, Chemical Engineering, Engineering +8

Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing

Yunpeng Yang, Jie Huang, Tao Wang et al. · Journal of Thoracic Oncology · 2021 · 43 citations · Full text

A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports.

Jing Jin, Yuan Tang, Chen Hu et al. · Journal of Clinical Oncology · 2021 · 39 citations

Surgical Oncology, Surgery, Treatment Verification +17